| Abram Jonathan Solano, | |
|
3530 Atlantic Ave Ste 203, Long Beach, CA 90807-4569 | |
| (562) 424-7289 | |
| Not Available |
| Full Name | Abram Jonathan Solano |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 3530 Atlantic Ave Ste 203, Long Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326760190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 108005 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abram Jonathan Solano, 34415 Road 603, Madera, CA 93638-8081 Ph: () - | Abram Jonathan Solano, 3530 Atlantic Ave Ste 203, Long Beach, CA 90807-4569 Ph: (562) 424-7289 |
News Archive
Researchers at New York University's Courant Institute of Mathematical Sciences have developed a new algorithm that can lead to more accurate detection of cancer genes than previous versions.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.
Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.
Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.
› Verified 1 days ago
Dr. Vincent Do, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 324 E Anaheim St, Ste C, Long Beach, CA 90813 Phone: 562-435-8100 | |
Mark T Arima, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2535 Pacific Ave, Long Beach, CA 90806 Phone: 562-424-5050 Fax: 562-997-0537 | |
Michael M. Le, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 2150 E South St, Ste. 116, Long Beach, CA 90805 Phone: 562-531-9779 Fax: 562-531-9779 | |
Dr. Celso Sy, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3601 Elm Ave, Long Beach, CA 90807 Phone: 562-427-8833 Fax: 562-394-0965 | |
Howard Morton Polk Iii, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 5901 E 7th St, Long Beach, CA 90822 Phone: 562-826-8000 | |
Dr. Maged Zaky Nessim, D.D.S.,INS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3440 Atlantic Ave Ste 2, Long Beach, CA 90807 Phone: 562-424-0724 Fax: 562-424-8433 | |
Daniel Hoa, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3943 E Anaheim St, Long Beach, CA 90804 Phone: 562-597-4500 |